How Much Radiation Is in a Mammogram?

A standard digital mammogram delivers roughly 2 mGy (milligray) of radiation to the breast per image, which works out to about 4 mGy for a typical two-view exam of one breast. That is a small fraction of the natural background radiation you absorb in a year just from living on Earth. But the number is not fixed: it shifts depending on how thick your breast tissue is, what type of machine the facility uses, and whether the exam involves newer techniques like 3D imaging or contrast dye. For most women over 40, the radiation risk from screening is vastly outweighed by the cancer deaths it prevents, though the math changes for certain groups.

The Actual Numbers Per View and Per Exam

The dose metric used in mammography is mean glandular dose (MGD), which estimates how much energy the radiation deposits in the glandular tissue of the breast, the tissue most sensitive to radiation damage. In a large U.S. screening trial comparing digital and older screen-film systems, the average MGD per view was about 1.86 mGy for digital mammography and 2.37 mGy for screen-film, making the digital systems roughly 22 percent lower in dose per image.¹ Screen-film mammography has largely been replaced by digital in most countries, so the lower number is what most women encounter today.

A routine screening exam usually involves two views of each breast, so four images total. In that same trial, the total per-subject dose averaged about 4.15 mGy for digital mammography when extra views were included, compared with about 5 mGy for screen-film.¹ If your radiologist requests additional spot-compression or magnification views because something looked ambiguous, the total dose for that visit goes up accordingly, but each extra view still falls in the same range per image.

Why Your Dose Can Differ From Someone Else’s

Mammography dose is not a one-size-fits-all number. Research consistently shows that compressed breast thickness is the single biggest factor. One study that modeled the relative contributions found that breast thickness accounted for about 76 percent of dose variability, with breast density adding another 8 percent and factors like body mass index and age contributing less than 1 percent each.² In practical terms, a woman with large, thick breasts will receive a measurably higher dose than a woman with thin, small breasts, simply because the X-ray tube has to work harder to get enough radiation through the tissue for a usable image.

Compression plays into this directly. The paddle that squeezes the breast flat during a mammogram is not just there to hold you still. Flattening the tissue means the X-rays travel through a shorter path, which lets the machine use a lower dose to produce a clear picture. It also spreads overlapping tissue apart so abnormalities are easier to see. Studies on compression confirm that thinner compressed thickness translates to lower absorbed dose while improving image quality.³ The discomfort is real, but there is a genuine dosimetric reason for it.

3D Mammography and How It Changes the Dose

Digital breast tomosynthesis, commonly marketed as “3D mammography,” takes a series of thin-slice images as the X-ray tube sweeps in an arc over the breast. Those slices are reconstructed into a quasi-three-dimensional picture, which helps radiologists see through overlapping tissue and has been shown to reduce callback rates for false alarms. The trade-off is more radiation per view.

How much more depends on the machine and the protocol. A European per-view comparison found that tomosynthesis delivered about 1.86 mGy versus 1.37 mGy for standard digital mammography, an average increase of roughly 38 percent per view, with individual cases ranging from 0 percent to 75 percent higher.⁴ Another study measuring in-vivo dose reported a similar increase of about 46 percent in average glandular dose for tomosynthesis relative to standard digital.⁵

A review that pooled findings from multiple studies noted a wide range, with the two-view tomosynthesis-to-FFDM dose ratio falling between 0.68 and 1.17, meaning some systems and settings actually delivered comparable or even slightly less dose than standard digital.⁶ The variation comes down to manufacturer, software generation, and whether the facility combines a standard 2D image with the 3D sweep or uses a synthetic 2D image reconstructed from the tomosynthesis data. Synthetic 2D eliminates the need for a separate full exposure, which keeps the total dose closer to a standard mammogram.

Contrast-Enhanced Mammography

Contrast-enhanced spectral mammography (CESM or CEM) is a newer technique in which an iodine-based contrast agent is injected intravenously before the images are taken. By acquiring images at two different energy levels, the system highlights areas of abnormal blood flow, similar in concept to breast MRI but done on a mammography machine. The extra energy needed for the high-energy exposure adds to the dose.

In one study comparing modalities at matched breast thicknesses, the average glandular dose was about 3.0 mGy per contrast-enhanced exposure, compared with 2.1 mGy for standard digital and 2.5 mGy for tomosynthesis.⁷ A two-center prospective study reported a mean dose of about 4.9 mGy for a two-view bilateral contrast-enhanced exam, roughly 30 percent higher than standard digital mammography.⁸ A systematic review that gathered per-view data from twelve studies found average glandular dose values ranging from 0.43 to 2.65 mGy per view, reflecting variability across equipment and protocols.⁹ Contrast-enhanced mammography is not used for routine screening in most settings; it tends to be reserved for problem-solving, high-risk surveillance, or situations where MRI is unavailable or contraindicated.¹⁰

Putting Mammogram Dose in Perspective

A total exam dose of about 4 mGy might sound alarming in the abstract, but some context helps. The average person in the United States receives roughly 3 mSv (millisieverts) per year from natural background radiation, from cosmic rays, radon gas in buildings, and radioactive elements in food and soil. A screening mammogram adds something on the order of 0.4 to 0.7 mSv to that annual tally, depending on the number of views and the conversion factors used. That is comparable to about seven weeks of background exposure. A chest X-ray, by comparison, delivers around 0.02 mSv, while a chest CT scan typically delivers several millisieverts. A mammogram falls somewhere between these two common medical exposures, much closer to the low end.

The breast tissue being imaged absorbs the dose directly, which is the reason the risk discussion focuses specifically on breast cancer rather than whole-body effects. Other organs receive only trace scatter radiation, which brings up a common question addressed later in this article.

The Risk-Benefit Balance for Average-Risk Women

The fear that mammography itself could cause cancer is one of the psychosocial factors that discourages some women from screening.¹¹ It is not irrational: ionizing radiation can cause DNA damage and downstream genomic instability in breast tissue.¹² The question is whether that theoretical harm is large enough to matter relative to the benefit of finding cancer early.

Modeling studies consistently find that the lives saved far outweigh the radiation-induced cancers. A widely cited U.S. modeling study projected that annually screening 100,000 women from age 40 to 74 would induce about 125 breast cancers and lead to roughly 16 radiation-caused deaths over those women’s lifetimes, while the early detection from that same screening would avert about 968 breast cancer deaths.¹³ That is a ratio of about 60 deaths averted for every one caused. A separate risk model likewise concluded that radiation risk should not be a deterrent for women over 40.¹⁴ A British analysis estimated lives-saved-to-radiation-induced-cancer ratios between 30:1 and 60:1, depending on assumptions about how effectively the body repairs low-dose DNA damage.¹⁵

These numbers apply to women at average risk beginning screening at 40. The balance shifts for younger women, where breast tissue is more radiosensitive, lifetime cumulative exposure would be higher, and breast cancer incidence is lower, so there are fewer cancers to catch early.

BRCA Mutation Carriers and Younger Women

The calculus changes meaningfully for women who carry BRCA1 or BRCA2 mutations. Their breast tissue appears more sensitive to radiation, and they already face a much higher lifetime breast cancer risk. A large retrospective study found that any diagnostic radiation exposure before age 30 was associated with roughly double the breast cancer risk in BRCA carriers, with a dose-response pattern: the highest quarter of cumulative exposure was associated with a nearly fourfold increase.¹⁶

A modeling study estimated that for BRCA1 carriers, annual mammography starting at age 25 to 29 would need to reduce breast cancer mortality by more than 50 percent just to break even against the radiation-induced cancers. Since mammography’s mortality reduction in young women is thought to be well below that threshold, the researchers concluded there would be no net benefit from annual mammographic screening of BRCA carriers before age 30, uncertain benefit at 30 to 34, and likely some net benefit from age 35 onward.¹⁷ This is one of the main reasons many guidelines recommend breast MRI, which uses no ionizing radiation, as the primary screening tool for high-risk young women, with mammography added later or used as a supplement. A separate case-control study looking at whether screening mammography itself raises breast cancer risk in BRCA carriers found no overall association, though the study was limited in its ability to detect effects from very early-age exposure.¹⁸

Breast Implants and Extra Dose

Women with breast implants generally receive more radiation during a mammogram because the standard technique involves additional views. The Eklund displacement technique pushes the implant back and pulls the breast tissue forward, but the implant itself is radiopaque, meaning the machine has to take views both with and without displacement to see all the tissue. That can mean eight images instead of the usual four. Older data on screen-film systems found that augmentation mammography could result in a total dose around 10.7 mGy, though dose-reduction techniques, including different target-filter combinations and limiting views to three rather than four per breast, cut that figure by about two-thirds to roughly 3.6 mGy.¹⁹ Modern digital systems have largely replaced the screen-film equipment used in that study, so actual doses today are likely lower, but the principle remains: more views mean more radiation, and implant exams require more views.

Do You Need a Thyroid Shield?

Social media posts periodically warn women to demand a thyroid shield during their mammogram, claiming that the radiation scatters up to the thyroid gland and causes thyroid cancer. The concern is understandable but overstated. A phantom and patient measurement study found that about half the dose reaching the thyroid during mammography comes from scatter off the machine’s collimator system rather than from radiation passing through the breast. Even so, the total thyroid dose was a tiny fraction of the dose to the breast itself.²⁰ The researchers noted that a thyroid collar is not mandatory in general, though it could be considered for younger women given their higher radiosensitivity.

A separate analysis concluded that thyroid shielding during mammography is unnecessary and may actually increase the number of retakes, since the collar can fall into the imaging field and obscure part of the breast, prompting a repeat exposure that adds more dose than the shield saved.²¹ In other words, insisting on a thyroid shield could paradoxically increase your total radiation exposure if it triggers a redo.

How Mammography Machines Are Regulated

In the United States, every facility offering mammography must comply with the Mammography Quality Standards Act (MQSA), which Congress enacted in 1992. The law requires accreditation by an approved body, annual inspections, and adherence to standards covering equipment performance, radiation dose limits, personnel qualifications, and image quality.²² Medical physicists test each machine regularly to verify that the dose delivered falls within acceptable ranges and that image quality meets minimum benchmarks.²³ Similar regulatory frameworks exist in Europe and other regions. This means the dose you receive is not arbitrary; it is constrained by regulatory limits that balance image quality against radiation exposure.

When Radiation-Free Alternatives Make Sense

Ultrasound and MRI both produce breast images without ionizing radiation. Ultrasound is particularly useful as a supplement for women with dense breast tissue, where mammography’s sensitivity drops. MRI is the most sensitive tool for detecting breast cancer and is the preferred primary screening method for women at high lifetime risk, including many BRCA carriers. A systematic review confirmed ultrasound’s strength in differentiating lesions in dense breasts and MRI’s precision, though MRI also carries higher false-positive rates, which can lead to unnecessary biopsies.²⁴

Neither ultrasound nor MRI has replaced mammography for general population screening. Ultrasound is operator-dependent and time-consuming for whole-breast surveys. MRI is expensive, requires contrast injection (with its own rare risks), and its high false-positive rate makes it impractical for screening millions of average-risk women. For most women, mammography remains the first-line screening tool precisely because it balances radiation dose, cost, accessibility, and diagnostic performance better than any single alternative. But if radiation is a particular concern for you, whether because of young age, genetic risk, or personal preference, discussing MRI or ultrasound supplementation with your doctor is reasonable.

How Radiation Actually Affects Breast Tissue

When X-ray photons pass through breast tissue, they can damage DNA strands directly or generate reactive oxygen species that damage DNA indirectly. The cell usually repairs these breaks without trouble. Occasionally, though, a repair goes wrong: a gene gets rearranged, a growth-suppression signal gets silenced, or the cell’s normal quality-control checkpoints fail. Research in animal models has shown that radiation exposure can alter DNA methylation patterns and activate signaling pathways involved in cell proliferation, shifting the tissue toward a state that is more permissive of abnormal growth.²⁵ The tissue environment also matters: radiation triggers inflammation and extracellular signaling that can influence neighboring cells’ behavior, a phenomenon sometimes called the bystander effect.²⁶

All of this happens in proportion to dose. At the doses involved in mammography, the probability of any single cell accumulating enough damage to become cancerous is extremely small. The risk is not zero in a strict mathematical sense, but it is small enough that, for women in the recommended screening age range, the chance of missing a treatable cancer by skipping mammography vastly exceeds the chance of developing one from the mammogram itself. The key insight from the modeling studies is that even when you assume the most conservative (least forgiving) estimates of radiation risk, mammography screening still comes out ahead by a wide margin for women over 40.